
|Articles|July 1, 2003
Inhibitor of neurotransmitters reduces SUI episodes
Author(s)Nicholas Mulcahy
Chicago-Women with stress urinary incontinence receiving an investigationalagent designed to inhibit two key neurotransmitters significantly showeda reduced number of weekly incontinence episodes and improvements in qualityof life compared with patients receiving placebo. The drug, duloxetine,is dual reuptake inhibitor of serotonin and norepinephrine currently inphase III development.
Advertisement
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Related Content
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA grants 510(k) clearance to Break Wave lithotripsy device for kidney stones
2
Study launches of MRI plus PSMA-PET imaging for prostate cancer detection
3
Initial ARID results published in World Journal of Urology as pivotal trial progresses
4
CaverSTIM device shows initial promise for post-prostatectomy erectile dysfunction
5


















